NCT02000388Unknown4 期
Efficacy and Safety of Intranasal Ketorolac Tromethamine (SPRIX) as a Short Term Pain Management Tool for Adult Male Patients With Post-Vasectomy Pain
Citrus Valley Medical Research, Inc.0 个研究点目标入组 15 人开始时间: 2012年2月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 发起方
- 入组人数
- 15
- 主要终点
- Pain Scores on the Visual Analog Scale
研究概览
简要总结
To evaluate the efficacy, tolerability and safety of intranasal ketorolac tromethamine (SPRIX) as an option for pain management in post vasectomy patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 25 Years 至 64 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Ketorolac tromethamine (SPRIX)
Other
A SPRIX dose will be one 15.75 mg spray in each nostril for a total dose of 31.5 mg which can be repeated every 6-8 hrs as needed for post vasectomy pain with a maximum daily dose of 126 mg to be continued for up to 5 days.
干预措施: Ketorolac Tromethamine (Drug)
Standard of care
Other
The intervention used will be standard of care
干预措施: Standard of Care (Other)
结局指标
主要结局
Pain Scores on the Visual Analog Scale
时间窗: 5 days
次要结局
- To determine Number of Participants with Adverse Events as a Measure of Safety and Tolerability(5 Days)
研究者
相似试验
已完成
4 期
Intranasal Ketorolac Tromethamine (Sprix) for Acute Pain of Interstitial Cystitis Flare of PainInterstitial CystitisNCT02000401Citrus Valley Medical Research, Inc.15
已完成
1 期
Intranasal (NAS) Ketamine for Cancer PainPainCancerNCT03146806Emory University10
已完成
2 期
Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of MigraineMigraineNCT00483717Egalet Ltd173
终止
2 期
Intranasal Ketamine In the Treatment of Pediatric Bipolar DisorderBipolar DisorderNCT01504659Juvenile Bipolar Research Foundation5
撤回
早期 1 期
Intranasal Ketamine for Suicidal Ideation in VeteransSuicidal IdeationNCT03788694Bronx Veterans Medical Research Foundation, Inc